Based on the forecasted data, sales of musculoskeletal system medicines in Italy are expected to decrease from 2.3% of total sales in 2024 to a steady 2.2% from 2025 to 2028. This indicates a slight decline of 0.1 percentage points reaching a plateau over the subsequent years. Given that sales accounted for 2.4% in 2023, the trend reflects a modest contraction in market share year-on-year.

Future trends to watch for include:

Potential impact of innovative therapies and technological advancement on market dynamics.
The influence of demographic shifts, particularly an aging population, on demand.
Policy changes related to healthcare spending and drug pricing regulations.